Filtered By:
Source: ScienceDaily Headlines
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 3 results found since Jan 2013.
Hope for reversing stroke-induced long-term disability
Permanent brain damage from a stroke may be reversible thanks to a developing therapeutic technique, a study has found. The novel approach combines transplanted human stem cells with a special protein that the US Food and Drug Administration already approved for clinical studies in new stroke patients. The researchers say they are the first to use 3K3A-APC to produce neurons from human stem cells grafted into the stroke-damaged mouse brain.
Source: ScienceDaily Headlines - August 22, 2016 Category: Science Source Type: news
Stroke recovery in mice improved by Ambien, study shows
Mice that had strokes rebounded significantly faster if they received low doses of a popular sleeping aid, according to researchers. Zolpidem, better known by the trade name Ambien, has long been approved by the U.S. Food and Drug Administration for treating insomnia. But it has never before been definitively shown to enhance recovery from stroke.
Source: ScienceDaily Headlines - December 18, 2015 Category: Science Source Type: news
FDA approves many drugs that predictably increase heart, stroke risk
The agency charged to protect patients from dangerous drug side effects needs to be more vigilant when it comes to medications that affect blood pressure. A clinical professor of family medicine has issued this call to the Food and Drug Administration. At issue is the apparent disconnect between what patients and doctors might consider "clinically significant" risk and the standards that some FDA reviewers apply when evaluating the safety of new therapeutics.
Source: ScienceDaily Headlines - May 27, 2014 Category: Science Source Type: news
